Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.61 |
| ▸ | HRH4 | Q9H3N8 | 3/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | THPO | P40225 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1537285 | 0.93 | CYP3A4 (0.71) | CYP3A4SLC7A5HRH4HRH3ALDH1A1 | |
| SCHEMBL163444 | 0.93 | CYP3A4 (0.71) | CYP3A4SLC7A5HRH4HRH3ALDH1A1 | |
| Hydrochloric Acid SCHEMBL28331180 | 0.91 | CYP3A4 (0.69) | CYP3A4SLC7A5HRH4HRH3ALDH1A1 | |
| SCHEMBL9635644 | 0.89 | CYP3A4 (0.56) | CYP3A4SLC7A5HRH4HRH3ALDH1A1 | |
| SCHEMBL9083164 | 0.87 | CYP3A4 (0.63) | CYP3A4SLC7A5HRH4HRH3ALDH1A1 | |
| SCHEMBL15911724 | 0.87 | CYP3A4 (0.63) | CYP3A4SLC7A5HRH4HRH3ALDH1A1 | |
| SCHEMBL9082370 | 0.87 | CYP3A4 (0.63) | CYP3A4SLC7A5HRH4HRH3ALDH1A1 | |
| SCHEMBL28328192 | 0.87 | CYP3A4 (0.67) | CYP3A4SLC7A5HRH4HRH3ALDH1A1 | |
| Sulfuric Acid SCHEMBL9797625 | 0.86 | CYP3A4 (0.61) | CYP3A4SLC7A5HRH4HRH3ALDH1A1 | |
| SCHEMBL3457999 | 0.86 | CYP3A4 (0.61) | CYP3A4SLC7A5HRH4HRH3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109022381-A | Amino acid dehydrogenase mutant and its application | 凯莱英生命科学技术(天津)有限公司 | 2018-12-18 | — | — | CN | claimed |
| WO-2003099322-A2 | IL-11 DERIVATIVES AND THERAPEUTIC USES THEREOF | ISIS INNOVATION LIMITED (GB) | 2003-12-04 | — | — | WO | claimed |
| EP-0829206-A1 | Edible micro-emulsion for coating food products and its use for browning and crisping in a microwave | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 1998-03-18 | — | — | EP | claimed |
| EP-0769549-A2 | Enzyme mutants having a low degree of variation of the molecular charge over a pH range | NOVO NORDISK A/S (DK) | 1997-04-23 | — | — | EP | claimed |
| WO-1992011357-A1 | ENZYME MUTANTS HAVING A LOW DEGREE OF VARIATION OF THE MOLECULAR CHARGE OVER A pH RANGE | NOVO NORDISK A/S (DK) | 1992-07-09 | — | — | WO | claimed |
| WO-2024117904-A1 | RECEPTOR- AND DRUG-DEPENDENT REGULATED ON-SITE PRODUCTION OF BIOLOGICALS | Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis (NL) | 2024-06-06 | — | — | WO | disclosed |
| EP-4372090-A2 | CRISPR-RELATED METHODS AND COMPOSITIONS WITH GOVERNING GRNAS | Editas Medicine, Inc. (US) | 2024-05-22 | — | — | EP | disclosed |
| CN-114940713-B | Anti-TRKB antibodies | 清华大学 | 2024-04-30 | — | — | CN | disclosed |
| US-20240132916-A1 | NUCLEASE-GUIDED NON-LTR RETROTRANSPOSONS AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2024-04-25 | — | — | US | disclosed |
| WO-2024081728-A2 | REPROGRAMMABLE TNPB POLYPEPTIDES WITH MAZE DOMAINS AND USES THEREOF | THE BROAD INSTITUTE, INC. (US) | 2024-04-18 | — | — | WO | disclosed |
| WO-2024081711-A2 | REPROGRAMABLE TNPB POLYPEPTIDES AND USE THEREOF | THE BROAD INSTITUTE, INC. (US) | 2024-04-18 | — | — | WO | disclosed |
| WO-2024073414-A2 | PROGRAMMABLE NUCLEASE-PEPTIDASE COMPOSITIONS | THE BROAD INSTITUTE, INC. (US) | 2024-04-04 | — | — | WO | disclosed |
| EP-0563169-B1 | ENZYME MUTANTS HAVING A LOW DEGREE OF VARIATION OF THE MOLECULAR CHARGE OVER A pH RANGE | NOVO NORDISK AS (DK) | 1997-10-29 | — | — | EP | disclosed |
| EP-0787186-A1 | NEURONAL APOPTOSIS INHIBITOR PROTEIN, GENE SEQUENCE AND MUTATIONS CAUSATIVE OF SPINAL MUSCULAR ATROPHY | UNIVERSITY OF OTTAWA (CA) | 1997-08-06 | — | — | EP | disclosed |
| EP-0769549-A2 | Enzyme mutants having a low degree of variation of the molecular charge over a pH range | NOVO NORDISK A/S (DK) | 1997-04-23 | — | — | EP | disclosed |
| WO-1996012016-A1 | NEURONAL APOPTOSIS INHIBITOR PROTEIN, GENE SEQUENCE AND MUTATIONS CAUSATIVE OF SPINAL MUSCULAR ATROPHY | THE UNIVERSITY OF OTTAWA (CA) | 1996-04-25 | — | — | WO | disclosed |
| WO-1994023030-A2 | METHODS AND MATERIALS RELATING TO THE FUNCTIONAL DOMAINS OF DNA BINDING PROTEINS | ARCH DEVELOPMENT CORPORATION (US) | 1994-10-13 | — | — | WO | disclosed |
| EP-0563103-A1 | ENZYMES AND ENZYMATIC DETERGENT COMPOSITIONS | UNILEVER PLC (GB) | 1993-10-06 | — | — | EP | disclosed |
| WO-1992011357-A1 | ENZYME MUTANTS HAVING A LOW DEGREE OF VARIATION OF THE MOLECULAR CHARGE OVER A pH RANGE | NOVO NORDISK A/S (DK) | 1992-07-09 | — | — | WO | disclosed |
| WO-1992011348-A1 | ENZYMES AND ENZYMATIC DETERGENT COMPOSITIONS | UNILEVER N.V. (NL) | 1992-07-09 | — | — | WO | disclosed |